Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[64Cu]Cu-NECT-224 is an experimental, clinical-stage PET radiotracer consisting of a copper-64-labeled bicyclic peptide that selectively targets Nectin-4, a cell adhesion protein overexpressed in various malignancies including urothelial carcinoma and triple-negative breast cancer. The peptide ligand is structurally derived from the bicyclic peptide-drug conjugate BT8009, with modifications such as the bioisosteric replacement of methionine to prevent oxidation and improve stability. Developed by researchers at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and TU Dresden, [64Cu]Cu-NECT-224 is designed for noninvasive imaging and quantification of Nectin-4 expression in tumors to support patient stratification for Nectin-4-targeted therapies. It has been evaluated in first-in-human PET/MRI studies in patients with urothelial carcinoma.
| Indication | Highest phase | Status |
|---|---|---|
| bladder cancer by histology | In development | Active |
| urethral urothelial carcinoma | In development | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: bladder cancer by histology
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [64Cu]Cu-NECT-224.
Work on [64Cu]Cu-NECT-224? Claim this page to correct or add information. Claim this page